PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2005

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2005
Quarter2
Financial Year End31/12/2005
The figureshave not been audited

Attachments

pharma_klse.doc
410 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2005


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2005 
30/06/2004 
30/06/2005 
30/06/2004 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
242,784
178,644
470,656
369,949
2Profit/(loss) before tax
14,312
16,264
32,561
36,933
3Profit/(loss)
after tax and minority
interest
8,711
10,882
19,410
23,266
4Net profit/(loss) for
the period
8,711
10,882
19,410
23,266
5Basic earnings/(loss) per share (sen)
8.51
10.77
19.00
23.05
6Dividend per share (sen)
0.00
4.50
0.00
4.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.5100
2.6000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Directors do not recommend any payment of interim dividend for the current period ended 30 June 2005 (2004:interim tax exempt dividend of 4.5 sen per share).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced18 Aug 2005  
CategoryFinancial Results
Reference NoCC-050817-32070